Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques-论文-万方医学网

首页> > Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

导出原文传递

翻译打印收藏纠错

第一作者： Jenkinsa, David

作者： Jenkinsa, David ^[1] ; Harmon, Christopher L. ^[2] ; Jia, Xiao ^[3] ; Kesselring, Allen ; Hatcher, Danielle ; Grayson, Katie ; Ayres, Jennifer

作者单位： FHI 360, Prod Qual & Compliance, 2810 Meridian Pkwy,Suite 160, Durham, NC 27713 USA ^[1] FHI 360, Prod Dev & Intro, 359 Blackwell St,Suite 200, Durham, NC 27701 USA ^[2] EKG Life Sci Solut, 4633 World Pkwy Circle, St Louis, MO 63134 USA ^[3]

关键词 Medroxyprogesterone acetate Forced degradation HPLC-MS/MS Quantitative structure activity relationships Toxicity risk

发布时间 2022-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

相似文献

同项目论文

相关期刊

检索历史 清除

Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques

相似文献

同项目论文

相关期刊

检索历史清除